Navigation Links
Ben-Gurion U researchers isolate microalgal strain that could reduce cholesterol
Date:5/3/2010

BEER-SHEVA, ISRAEL, May 3, 2010 Ben-Gurion University of the Negev (BGU) researchers have isolated a microalgal strain which produces large amounts of a polyunsaturated fatty acid that could reduce blood pressure, chronic inflammation and blood cholesterol level, reducing the risk for heart attacks.

A research team at BGU's Landau Family Microalgal Biotechnology Lab in the Jacob Blaustein Institutes for Desert Research (BIDR) headed by Prof. Zvi HaCohen, is studying an algal mutant that is capable of accumulating up to 15 percent (of dry weight) of a polyunsaturated fatty acid (PUFA) called DGLA (Dihomo-γ-Linolenic Acid). The new strain, IKG-1, is a freshwater microalga that the researchers believe is the only known plant source capable of producing such significant amounts of DGLA.

"Omega-6 PUFA are necessary as components of brain cell membranes and have various nutritional uses," explains HaCohen, incumbent of the Maks and Rochelle Etingin Chair in Desert Research and rector-elect at BGU. "DGLA is one of these PUFA, but appears in nature only as an intermediate in the biosynthesis of other compounds and does not accumulate to any appreciable concentration. There is no natural source for DGLA and although its beneficial effects are well known, very few clinical studies have been conducted."

The research team also included the director of the Landau Laboratory, Prof. Sammy Boussiba; director of the BIDR Prof. Avigad Vonshak; Dr. Inna Khozin-Goldberg; and Ph.D. student Pushkar Shrestha.

"The significant discovery of the IKG-1 microalgal mutant and its high content of DGLA could impact treatment of life-threatening diseases, such as chronic inflammations, multiple sclerosis and arteriosclerosis," explains Dr. Ora Horovitz, vice president of business development for BGN Technologies, the technology transfer and commercialization subsidiary of BGU.

"Our Microalgal Biotechnology Laboratory continues to be a leading innovator in its work on microalgae and its products harnessing Negev resources, such as brackish water and highly abundant sunlight. BGU is continuing to develop valuable pharmaceuticals and nutraceuticals, as well as biofuels and other potential alternative energy sources."


'/>"/>

Contact: andrewlavin@alavin.com
andrewlavin@alavin.com
516-944-4486
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Related biology news :

1. Uniform method to interpret autism spectrum disorders is defined at Ben-Gurion University
2. Anti-inflammatory drugs (coxibs) interfere with aspirins clotting ability -- Ben-Gurion U.
3. Heartburn drugs deemed safe for fetuses according to Ben-Gurion University researchers
4. Ben-Gurion University Alzheimers researcher demonstrates specific immune response to vaccine
5. Ben-Gurion University of the Negev technology being developed for use in Jordan desalination plant
6. Ben-Gurion U. developing new computer techniques to analyze historic Hebrew and Arabic documents
7. 1 in 6 health workers wont report in flu pandemic -- study by Ben-Gurion U. researchers
8. Ben-Gurion U. researchers reveal connection between cancer and human evolution
9. Ben-Gurion University research and technology used in new solar energy farm
10. Ben-Gurion University of the Negev signs collaborative contract with Bayer CropScience
11. Ben-Gurion University engineers develop technique to help combat nuclear proliferation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... VIEW, Calif. , March 9, 2017 ... 23andMe , the leading personal genetics company, are using ... now provide customers with personalized nutrition plans that consider ... but also genetic markers impacting how their body may ... food decision support platform uses biometrics such as Body ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... Germany , February 28, 2017 News ... ... Amsterdam from 14 to 16 March, Materna ... destination, and show how seamless travel is a real benefit for ... has added biometrics to their passenger touch point solutions to take ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... Calif. , March 28, 2017 ... of international life sciences corporation Anpac Bio-Medical ... set a new, international record, processing and reporting ... "Cancer Differentiation Analysis" (CDA) liquid biopsy ... World Nobel Prize Laureate Summit publications, Anpac Bio,s ...
(Date:3/28/2017)... ... 2017 , ... LabKey and collaborator Just Biotherapeutics, Inc. (Just) ... LabKey Biologics . Built in collaboration with Just and designed with input from ... research teams tools for biological entity registration, assay data integration, and workflow management ...
(Date:3/28/2017)... , March 28, 2017 ... volatile and unpredictable sector due to the scientifically ... served include medical, agricultural, environmental, and industrial. In today,s ... stocks: Portola Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience Inc. ... Ocular Therapeutix Inc. (NASDAQ: OCUL ). ...
(Date:3/28/2017)... 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) ... safety and clinical data from its phase 1/2 tendon repair ... follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. ... The ... profile at 6 months and showed no serious adverse events ...
Breaking Biology Technology: